Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Ambry Genetics Initiates Fluidigm-Based Genomic Research Services

Published: Friday, April 13, 2012
Last Updated: Friday, April 13, 2012
Bookmark and Share
Gene expression, SNP genotyping and sample prep for targeted sequencing.

Ambry Genetics announced the launch of Fluidigm BioMark™ HD and Access Array™ System-based genomic research services. These services provide gene expression, SNP genotyping, and sample preparation for targeted sequencing using next-generation sequencers, focused on the genomics research market.

The BioMark HD System is one of the most advanced genomic analysis instruments on the market today. It provides the sensitivity and throughput needed to study gene expression profiles down to the single-cell level, as well as high throughput SNP genotyping and digital PCR for copy number variation and rare mutation detection. The Access Array System enables high-throughput, target-enrichment for all of the major next-generation sequencing instruments and allows users to enrich multiple unique targets (such as exons) from a large number of samples, all at one time and at low cost.

Ambry Genetics offers a wide variety of genomic services that will be enhanced by the addition of Fluidigm platforms. Separately, from a regulatory standpoint Ambry can offer its other services within a CLIA setting and deliver the highest quality of data, while handling large volumes of samples with automation in place.

“For months, many of our genomics customers have been clamoring for Fluidigm technologies from single-cell gene expression to sample prep for targeted resequencing. We are ready to unleash the power of Fluidigm platforms and are anxious to offer our customers these enhanced capabilities,” said Charles Dunlop, Chief Executive Officer of Ambry Genetics. “Over the past decade, Ambry Genetics has developed one of the best reputations in the genomics industry, and a big reason is our many technology platforms and our technical abilities to apply them. Having the Fluidigm technology in house is a major step forward for us, and will continue to solidify Ambry’s reputation as a leader in this space,” Dunlop concluded.

"Ambry Genetics has a first-class reputation as an adopter of leading technologies. We at Fluidigm are thrilled that our products will be part of Ambry's portfolio of services, and we are excited about the prospect of working closely together. With the combined expertise, customer focus, and technological prowess of Fluidigm and Ambry, we are confident we will deliver a new level of value to Ambry's customers," said Gajus Worthington, President and Chief Executive Officer of Fluidigm.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
HPV Genomes Show Greater Diversity Than Expected in Cancer Patients
The findings could have implications for eventually understanding why some cervical lesions become malignant.
Rapidly Detecting Drug-Resistant HepC
A nested PCR-based assay has been shown to rapidly and accurately detect drug-resistant strains of the hepatitis C virus.
Researchers Seek Water Test for Invasive Species Detection
Detecting invasive lake and river species using just a water sample would be a dream come true for wildlife managers and regulators in the state and University of Maine researchers may soon make this an inexpensive reality.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Ebola Assays Compared in Head-to-Head Analysis
A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!